美康生物品牌怎么样 申请店铺

我要投票 美康生物在医疗器械行业中的票数:947 更新时间:2026-01-08
美康生物是哪个国家的品牌?「美康生物」是美康盛德旗舰店旗下著名品牌。该品牌发源于浙江省宁波市,由创始人邹 * 德在2003年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力美康生物品牌出海!将品牌入驻外推网,定制美康生物品牌推广信息,可以显著提高美康生物产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

美康生物怎么样

美康生物是一家专业从事医学诊断产品研发、生产、销售及服务的企业。公司创立于2003年,矗立于宁波,2015年在深交所创业板成功上市,股票代码300439。

美康生物主要产业为体外诊断试剂、仪器及独立第三方医学诊断服务。公司秉承以人为本、科技创新的宗旨来建立自己的特色,严格按照GMP标准组织生产。目前已取得140余项体外诊断试剂产品注册证书,是我国生化诊断试剂领域品种齐全的供应商之一;并取得9项诊断仪器产品注册证书,是行业内同时能够提供诊断试剂和诊断仪器的少数供应商之一。

公司打造以提供区域性医学检验服务为核心的第三方医学检验中心。拥有自主研发的区域LIS系统、现代化消毒中心、冷链物流系统、美康云平台等多项配套系统。大力助推分级诊疗的落地,加快各级医疗机构信息化改革的步伐,提升医院的管理水平、服务质量及综合竞争力。

美康生物成为医学检验集约化系统供应商,为客户提供实验室整体解决方案。公司将持续推出高科技含量产品,深入提供服务,为客户创造价值,为中国体外诊断事业的发展,为中国人民的健康做出更大贡献!


Meikang biology is a professional enterprise engaged in the research and development, production, sales and service of medical diagnosis products. Founded in 2003 and standing in Ningbo, the company was successfully listed on the growth enterprise market of Shenzhen Stock Exchange in 2015, with the stock code of 300439. Our main industries are in vitro diagnostic reagents, instruments and independent third-party medical diagnostic services. The company adheres to the tenet of people-oriented and scientific and technological innovation to establish its own characteristics and organize production in strict accordance with GMP standards. At present, it has obtained more than 140 in vitro diagnostic reagent product registration certificates, and is one of the suppliers with complete varieties in the field of biochemical diagnostic reagents in China. It has also obtained 9 registration certificates of diagnostic instrument products, which is one of the few suppliers in the industry that can provide diagnostic reagents and diagnostic instruments at the same time. The company has built a third-party medical testing center with the core of providing regional medical testing services. It has self-developed regional LIS system, modern disinfection center, cold chain logistics system, Meikang cloud platform and other supporting systems. Vigorously promote the implementation of hierarchical diagnosis and treatment, accelerate the pace of information-based reform of medical institutions at all levels, and improve the management level, service quality and comprehensive competitiveness of hospitals. Meikang biology has become a supplier of intensive medical testing system, providing customers with overall laboratory solutions. The company will continue to launch high-tech products, provide in-depth services, create value for customers, and make greater contributions to the development of China's in vitro diagnostic industry and the health of the Chinese people!

本文链接: https://brand.waitui.com/eed8e50ac.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

唐人神:2025年生猪销售收入84.79亿元,同比上升8%

36氪获悉,唐人神公告,公司2025年12月生猪销量49.46万头,同比下降10.46%,环比上升8.35%;销售收入合计6.27亿元,同比下降35.65%,环比下降0.28%。2025年1—12月累计生猪销量533.25万头,同比上升22.98%;销售收入84.79亿元,同比上升8%。2025年12月公司生猪销售收入同比下降的主要原因是生猪销售价格同比大幅下降及生猪出栏量减少。

2小时前

Mobileye拟9亿美元收购人形机器人初创企业曼蒂机器人

以色列自动驾驶技术企业Mobileye全球公司于周二宣布,将以约9亿美元的价格收购人形机器人初创企业Mentee机器人公司。此举标志着该公司押注其眼中的人工智能下一个前沿领域。(新浪财经)

2小时前

美股大型科技股盘前多数下跌,Meta跌0.4%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,Meta跌0.4%,谷歌跌0.37%,苹果跌0.2%,微软跌0.13%,亚马逊跌0.1%;英伟达涨0.62%,特斯拉涨0.26%,奈飞涨0.24%。

2小时前

热门中概股美股盘前多数下跌,网易跌超2%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,网易跌超2%,阿里巴巴、京东、小马智行、腾讯音乐跌超1%;爱奇艺涨近1%,百度涨0.16%。

2小时前

亿晶光电:2025年度净利润预亏

36氪获悉,亿晶光电公告,预计2025年度归属于上市公司股东的净利润为负值,2025年度经营业绩将出现亏损,且亏损金额预计将会超过上一年度经审计的净资产,公司2025年度期末净资产可能为负值。

2小时前

本页详细列出关于美康生物的品牌信息,含品牌所属公司介绍,美康生物所处行业的品牌地位及优势。
咨询